SFL plans to host a conference call and webcast for all stakeholders and interested parties on Wednesday, May 14, 2025, at 10 ...

Sneak peek at upcoming San Diego community events street fairs, festivals, concerts, performances, art shows, community ...

The turnaround in the Reit space comes at a time when gross leasing of commercial office space touched a historic high of 79 ...

Biocon Biologics has secured multiple market access agreements for Yesintek (ustekinumab-kfce), its biosimilar to Stelara ...

Biocon Biologics' Yesintek, a biosimilar to Stelara, has secured significant market access in the US, covering over 100 ...

Biocon Biologics secures multiple market access agreements in the US for its biosimilar, Yesintek, for treating Crohn's ...

Good morning, and welcome to the Palomar Holdings, Inc. first quarter 2025 earnings conference call. (Operator Instructions) As a reminder, this conference call is being recorded. I would now like to ...

Biocon Biologics Ltd., today announced the Company has secured multiple market access agreements for Yesintek™ ...

The drug has been chosen as the sole ustekinumab by BCBSM, Florida Healthcare Plan, and other closed-door health systems.

CNW/ -- (NYSE: SUN) ("Sunoco" or the "Partnership") and Parkland Corporation (TSX: PKI) ("Parkland") announced today that the ...

Sempra ( NYSE: SRE) Q1 2025 Earnings Conference Call May 8, 2025 12:00 PM ET Good day, and welcome to Sempra’s First Quarter Earnings Call. Today's conference is being recorded. At this time, I'd like ...

CAMBRIDGE, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), (Seres or the Company), a leading ...